REGN5713
R5713-5715-ALG-2556
Phase 3 small_molecule active
Quick answer
REGN5713 for Allergic Conjunctivitis is a Phase 3 program (small_molecule) at REGENERON PHARMACEUTICALS, INC. with 2 ClinicalTrials.gov record(s).
Program details
- Company
- REGENERON PHARMACEUTICALS, INC.
- Indication
- Allergic Conjunctivitis
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active